Get my own profile
Public access
View all17 articles
2 articles
available
not available
Based on funding mandates
Co-authors
Mikhail SavitskiEMBLVerified email at embl.de
Isabelle BecherEMBL HeidelbergVerified email at embl.de
André MateusAssistant Professor at Umeå University | Team Leader at Molecular Infection Medicine Sweden (MIMS)Verified email at umu.se
Marcus BantscheffCellzome, a GSK companyVerified email at gsk.com
Wolfgang HuberEMBL - European Molecular Biology LaboratoryVerified email at embl.org
Holger FrankenGSKVerified email at holgerfranken.de
Dominic HelmProteomics Core Facility, DKFZVerified email at dkfz-heidelberg.de
Nassos TypasGroup Leader, EMBLVerified email at embl.de
Sindhuja SridharanECR (Lecturer), Blizard Institute, Barts and The London School of Medicine andVerified email at qmul.ac.uk
Giovanna BergaminiCellzome GmbH, a GSK companyVerified email at GSK.com
Martin BeckMax Planck Institute of BiophysicsVerified email at biophys.mpg.de
Carl HerrmannProfessor of Bioinformatics - IPMB - Heidelberg UniversityVerified email at uni-heidelberg.de
Bernhard KusterProfessor for Proteomics and BioanalyticsVerified email at tum.de
Johannes F. HevlerStanford UniversityVerified email at stanford.edu
Simon AndersBioquant Center, University of HeidelbergVerified email at fs.tum.de
Sebastian SteinhauserNovartis Institutes for BioMedical Research - Discovery Sciences Data ScienceVerified email at novartis.com
Natalie RomanovEMBL HeidelbergVerified email at embl.de
Pedro BeltraoAssociate Professor, ETH ZurichVerified email at ethz.ch
Karsten BachPostdoctoral researcher, ETH ZurichVerified email at bsse.ethz.ch
Daniel HuebschmannClinician scientist, group leader National Center for Tumor Diseases (NCT) Heidelberg and GermanVerified email at dkfz-heidelberg.de